CureVac N.V. financials at a glance

+ Portfolio

The revenue of CureVac N.V. is reported as 0.06422 billion Dollars in the fiscal year 2023. The earnings were -0.93 Dollars per share in 2023, which was 68.42 higher than 2021. And about -0.054 billion Dollars are reported as free cash flow in the financials of CureVac N.V. 2023. No dividends were paid to the shareholders of the CureVac N.V. stock NasdaqGM:CVAC in the financial year 2023.

$67.42M

Revenue

$-1.32

Earnings Per Share

-,135.79%

Gross Margin %

$-,374.20M

Free Cash Flow

Revenue

67.42

Earnings Per Share

-1.32

Gross Margin %

-,135.79

Free Cash Flow

-,374.20

Financials

Year	Year	TTM	2022	2021	2020
Rev.	Revenue	N/A	$67.42M	$102.99M	$48.90M
GM %	Gross Margin %	-,193.25%	-,135.79%	-,109.02%	71.10%
OM	Operating Margin	0.00%	0.00%	0.00%	-,273.27%
EPS	Earnings Per Share	$-1.42	$-1.32	$-4.18	$-0.98
Div.	Dividends	N/A	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	-0.00%
Sha.	Shares	N/AM	194.95M	187.03M	180.46M
OCF	Operating Cash Flow	N/A	$-,286.18M	$-,733.13M	$522.40M
FCF	Free Cash Flow	N/A	$-,374.20M	$-,857.35M	$486.07M
FCFS	Free Cash Flow Per Share	$-1.57	$-2.01	$-4.63	$3.59

CureVac N.V. financials at a glance

Financials

Discover